Factors Influencing Chemotherapy-Induced Taste Alterations in Cancer Patients Receiving Cisplatin Treatment: A Path Analysis
Open Access
- 30 July 2025
- journal article
- Published by SAGE Publications in Cancer Control
- Vol. 32
Abstract
Introduction: Cisplatin is particularly recognized for its adverse effects, most notably its impact on chemosensory perception. Methods: This cross-sectional study enrolled 98 cancer patients undergoing cisplatin therapy from April 2022 to December 2023. Patients were administered the Chemotherapy-Induced Taste Alteration Scale (CITAS) and the Rhodes Index of Nausea, Vomiting, and Retching (RINVR). Results: A multiple linear regression model was employed to determine the effect of taste changes among cancer patients undergoing cisplatin therapy. The study of the model coefficients for the structural model (χ 2 /df = 1.338, P = .004, GFI = 0.955, CFI = 0.986, RMSEA = 0.063, SRMR = 0.079) demonstrated a robust match. This model, formed to evaluate the effects of taste alteration, appetite loss, nausea, vomiting, age, quality of life, and body surface area, was statistically significant and explained 76.4% of the variation. Multiple linear regression evaluations determined significant factors affecting taste alteration associated with nausea-vomiting [(95% CI: 0.111-0.244); P = 0.042], loss of appetite [(95% CI: 0.102-0.254); P = 0.000], age [(95% CI: −0.827-0.424); P = 0.001], quality of life [(95% CI: −0.908-0.489); P = 0.000], and body surface area [(95% CI: 0.024-0.098); P = 0.021]. Conclusion: Taste alteration significantly influenced symptoms of appetite loss, nausea, vomiting, age, and body surface area. These results provide valuable insights for developing effective intervention strategies to alleviate the relational effects of symptom clusters on patients’ quality of life and symptoms, particularly for cancer patients receiving cisplatin therapy.Keywords
This publication has 31 references indexed in Scilit:
- Cisplatin chemotherapy induces odor perception changes in bronchial cancer patientsLung Cancer, 2013
- Cisplatin-Induced Anorexia and Ghrelin2013
- Reduced Ghrelin Secretion in the Hypothalamus of Rats due to Cisplatin-Induced AnorexiaEndocrinology, 2010
- A systematic review of dysgeusia induced by cancer therapiesSupportive Care in Cancer, 2010
- Qualitative and Quantitative Assessment of Taste and Smell Changes in Patients Undergoing Chemotherapy for Breast Cancer or Gynecologic MalignanciesJournal of Clinical Oncology, 2009
- Taste and Smell Changes in Patients Receiving Cancer ChemotherapyCancer Nursing, 2009
- Serotonin and the Orchestration of Energy BalanceCell Metabolism, 2007
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational StudiesAnnals of Internal Medicine, 2007
- Chemosensory Dysfunction Is a Primary Factor in the Evolution of Declining Nutritional Status and Quality of Life in Patients With Advanced CancerJournal of Pain and Symptom Management, 2007
- Ghrelin and Feedback Systems2007